Cheil Bio Co

Cheil Bio Co EBIT Growth

Delisted·Feb 25, 2026

The Year-over-Year EBIT Growth of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 47.38 %. In the previous year, Year-over-Year EBIT Growth was -28.53 % — a change of -266.08% (higher).

EBIT Growth

47.38 %

YoY

-266.08%

Last updated:

Year-over-Year EBIT Growth of Cheil Bio Co is 2024 47.38 % . Year-over-Year EBIT Growth of Cheil Bio Co was 2023 -28.53 % . It decreases by -266.08% higher compared to the previous year.

The Cheil Bio Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2017
42.41 KRW
Jan 1, 2018
26.01 KRW
Jan 1, 2019
-64.18 KRW
Jan 1, 2020
-197.50 KRW
Jan 1, 2021
-253.57 KRW
Jan 1, 2022
9.06 KRW
Jan 1, 2023
-28.53 KRW
Jan 1, 2024
47.38 KRW
The Cheil Bio Co EBIT Growth history
YEAREBIT GrowthYoY
47.38 %-266.08%
-28.53 %-414.85%
9.06 %-103.57%
-253.57 %+28.39%
-197.50 %+207.74%
-64.18 %-346.74%
26.01 %-38.67%
42.41 %-269.34%
-25.05 %-1,396.77%
1.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Year-over-Year EBIT Growth of Cheil Bio Co is 47.38 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Cheil Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Cheil Bio Co

All Key Metrics — Cheil Bio Co